CRISPR/Cas9 technology generated a G to C change resulting in a valine to leucine substitution which is analogous to the human pathogenic p.Val380Leu variant found in a family with a male presenting with total fertilization failure. (J:303517)
查看原文 参与反馈
CRISPR/Cas9 technology generated a G to C change resulting in a valine to leucine substitution which is analogous to the human pathogenic p.Val380Leu variant found in a family with a male presenting with total fertilization failure. (J:303517)